nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase 1 study of OSI-930 in combination with erlotinib in patients with advanced solid tumours
|
Macpherson, I.R. |
|
2013 |
49 |
4 |
p. 782-789 8 p. |
artikel |
2 |
Case report: Stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue
|
Ernst, Erik |
|
2013 |
49 |
4 |
p. 911-914 4 p. |
artikel |
3 |
Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia
|
Lybol, C. |
|
2013 |
49 |
4 |
p. 860-867 8 p. |
artikel |
4 |
Determinants and interpretation of death certificate only proportions in the initial years of newly established cancer registries
|
Brenner, Hermann |
|
2013 |
49 |
4 |
p. 931-937 7 p. |
artikel |
5 |
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d’Etude des Lymphomes de l’Adulte (GELA)
|
Ribrag, Vincent |
|
2013 |
49 |
4 |
p. 904-910 7 p. |
artikel |
6 |
Excellent performance of Hemoccult Sensa in organised colorectal cancer screening
|
Kershenbaum, Anne |
|
2013 |
49 |
4 |
p. 923-930 8 p. |
artikel |
7 |
Impact of dendritic cell vaccines pulsed with Wilms’ tumour-1 peptide antigen on the survival of patients with advanced non-small cell lung cancers
|
Takahashi, Hidenori |
|
2013 |
49 |
4 |
p. 852-859 8 p. |
artikel |
8 |
Intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumours: Results from the expansion cohort of a phase I study
|
Khayat, David |
|
2013 |
49 |
4 |
p. 790-797 8 p. |
artikel |
9 |
IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness
|
Pavan, Simona |
|
2013 |
49 |
4 |
p. 964-973 10 p. |
artikel |
10 |
Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells
|
Le Magnen, Clémentine |
|
2013 |
49 |
4 |
p. 955-963 9 p. |
artikel |
11 |
LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma
|
Wang, Hui |
|
2013 |
49 |
4 |
p. 974-983 10 p. |
artikel |
12 |
Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)
|
Park, Jeong-Yeol |
|
2013 |
49 |
4 |
p. 868-874 7 p. |
artikel |
13 |
Menopausal symptoms and the risk of young-onset breast cancer
|
Fei, Chunyuan |
|
2013 |
49 |
4 |
p. 798-804 7 p. |
artikel |
14 |
Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: A 10-year single institution retrospective study
|
Hong, Nicole J. Look |
|
2013 |
49 |
4 |
p. 875-883 9 p. |
artikel |
15 |
Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation
|
Kim, Beom Kyung |
|
2013 |
49 |
4 |
p. 826-834 9 p. |
artikel |
16 |
Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: Formal consensus method for the development of guidelines for standardised time-to-event endpoints’ definitions in cancer clinical trials
|
Bellera, Carine A. |
|
2013 |
49 |
4 |
p. 769-781 13 p. |
artikel |
17 |
Recall mammography and psychological distress
|
Schou Bredal, Inger |
|
2013 |
49 |
4 |
p. 805-811 7 p. |
artikel |
18 |
Relapses in hepatoblastoma patients: Clinical characteristics and outcome – Experience of the International Childhood Liver Tumour Strategy Group (SIOPEL)
|
Semeraro, M. |
|
2013 |
49 |
4 |
p. 915-922 8 p. |
artikel |
19 |
Risk stratification models and mutational analysis: Keys to optimising adjuvant therapy in patients with gastrointestinal stromal tumour
|
Gronchi, Alessandro |
|
2013 |
49 |
4 |
p. 884-892 9 p. |
artikel |
20 |
Safety of multikinase inhibitors in metastatic renal cell carcinoma and indirect treatment comparisons
|
Catalá-López, Ferrán |
|
2013 |
49 |
4 |
p. 984-985 2 p. |
artikel |
21 |
Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: A systematic review and meta-analysis
|
Glechner, Anna |
|
2013 |
49 |
4 |
p. 812-825 14 p. |
artikel |
22 |
Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: A meta analysis
|
An, Xin |
|
2013 |
49 |
4 |
p. 843-851 9 p. |
artikel |
23 |
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)
|
Al-Batran, Salah-Eddin |
|
2013 |
49 |
4 |
p. 835-842 8 p. |
artikel |
24 |
The hazards of cross comparing the drug toxicity results from different trials in metastatic renal cancer: In response to a letter from Dr. Catalá-López
|
Powles, Thomas |
|
2013 |
49 |
4 |
p. 986-987 2 p. |
artikel |
25 |
The TLR4 gene polymorphisms and susceptibility to cancer: A systematic review and meta-analysis
|
Zhang, Kui |
|
2013 |
49 |
4 |
p. 946-954 9 p. |
artikel |
26 |
Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: A prospective observational multicentre study
|
Friedrich, Carsten |
|
2013 |
49 |
4 |
p. 893-903 11 p. |
artikel |
27 |
Tumor-associated antigenic pattern in squamous cell carcinomas of the head and neck – Analysed by SEREX
|
Heubeck, Bernd |
|
2013 |
49 |
4 |
p. e1-e7 nvt p. |
artikel |
28 |
Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level
|
Veitonmäki, Thea |
|
2013 |
49 |
4 |
p. 938-945 8 p. |
artikel |